These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7575177)

  • 41. Surgical castration but not immuncastration is associated with reduced hypothalamic GnIH and GHRH/GH/IGF-I axis function in male rats.
    Han X; Li J; Cao X; Du X; Meng F; Zeng X
    Theriogenology; 2016 Jul; 86(2):657-65. PubMed ID: 27020878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone-releasing factor regulation by somatostatin, growth hormone and insulin-like growth factor I in fetal rat hypothalamic-brain stem cell cocultures.
    Fernández Vázquez G; Cacicedo L; de los Frailes MT; Lorenzo MJ; Tolón R; Sánchez Franco F
    Neuroendocrinology; 1993 Dec; 58(6):655-65. PubMed ID: 7907399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
    Müller EE; Locatelli V; Ghigo E; Cella SG; Loche S; Pintor C; Camanni F
    Drugs; 1991 Feb; 41(2):161-77. PubMed ID: 1709847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.
    Tannenbaum GS; Bowers CY
    Endocrine; 2001 Feb; 14(1):21-7. PubMed ID: 11322498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
    Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
    Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The release of growth hormone (GH): relation to the thyrotropic- and corticotropic axis in the chicken.
    Kühn ER; Geelissen SM; Van der Geyten S; Darras VM
    Domest Anim Endocrinol; 2005 Jul; 29(1):43-51. PubMed ID: 15927766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I.
    Uchiyama T; Kaji H; Abe H; Chihara K
    Neuroendocrinology; 1994 May; 59(5):441-50. PubMed ID: 7912818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A postweaning reduction in circulating ghrelin temporarily alters growth hormone (GH) responsiveness to GH-releasing hormone in male mice but does not affect somatic growth.
    Ariyasu H; Iwakura H; Yamada G; Kanamoto N; Bando M; Kohno K; Sato T; Kojima M; Nakao K; Kangawa K; Akamizu T
    Endocrinology; 2010 Apr; 151(4):1743-50. PubMed ID: 20185766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
    Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
    Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat.
    Locatelli V; Grilli R; Torsello A; Cella SG; Wehrenberg WB; Müller EE
    Pediatr Res; 1994 Aug; 36(2):169-74. PubMed ID: 7970930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspects of growth hormone control in diabetes.
    Hyer SL; Kohner EM
    Aust N Z J Ophthalmol; 1990 Feb; 18(1):33-9. PubMed ID: 2113400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
    Maiter D; Underwood LE; Martin JB; Koenig JI
    Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of the pituitary-specific transcription factor GHF-1/Pit-1 messenger ribonucleic acid levels by growth hormone-secretagogues in rat anterior pituitary cells in monolayer culture.
    Soto JL; Castrillo JL; Dominguez F; Dieguez C
    Endocrinology; 1995 Sep; 136(9):3863-70. PubMed ID: 7649093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrahypothalamic actions of somatostatin and growth hormone releasing factor on growth hormone secretion.
    Willoughby JO; Brogan M; Kapoor R
    Neuroendocrinology; 1989 Nov; 50(5):592-6. PubMed ID: 2575238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered growth hormone (GH) secretion in vivo and in vitro in the diabetes-prone BB/Worcester rat.
    Nieves-Rivera F; Kerrigan JR; Krieg RJ; Egan J; Hwang LJ; Truumees E; Veldhuis JD; Evans WS; Rogol AD
    Growth Regul; 1993 Dec; 3(4):235-44. PubMed ID: 7907510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of hypoglycemia on the content of pituitary growth hormone (GH) and hypothalamic growth hormone-releasing factor (GHRF) in the rat.
    Katz SH; Dhariwal AP; McCann SM
    Endocrinology; 1967 Aug; 81(2):333-9. PubMed ID: 4952849
    [No Abstract]   [Full Text] [Related]  

  • 59. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Existence of somatotrope subpopulations which are differentially responsive to insulin-like growth factor I and somatostatin.
    Hoeffler JP; Hicks SA; Frawley LS
    Endocrinology; 1987 May; 120(5):1936-41. PubMed ID: 2882999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.